X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (42) 42
female (32) 32
adult (30) 30
middle aged (29) 29
index medicus (28) 28
male (28) 28
mutation (28) 28
aged (23) 23
genetic aspects (16) 16
aged, 80 and over (12) 12
dna mutational analysis (12) 12
oncology (12) 12
proto-oncogene proteins c-kit - genetics (11) 11
gene (10) 10
mastocytosis (10) 10
genes (9) 9
immunohistochemistry (9) 9
pathology (9) 9
poland (9) 9
adolescent (8) 8
analysis (8) 8
association (8) 8
c-kit (8) 8
mutations (8) 8
gastrointestinal stromal tumors - genetics (7) 7
genetics & heredity (7) 7
research (7) 7
young adult (7) 7
atherosclerosis (6) 6
base sequence (6) 6
care and treatment (6) 6
child (6) 6
familial hypercholesterolemia (6) 6
genetics (6) 6
genotype (6) 6
imatinib (6) 6
imatinib mesylate (6) 6
kit (6) 6
ovarian cancer (6) 6
receptor, platelet-derived growth factor alpha - genetics (6) 6
tumors (6) 6
animals (5) 5
cancer (5) 5
dna (5) 5
exons (5) 5
gastrointestinal stromal tumors (5) 5
gene mutations (5) 5
pdgfra (5) 5
polymerase chain reaction (5) 5
population (5) 5
prevalence (5) 5
risk (5) 5
risk factors (5) 5
anopheles (4) 4
antineoplastic agents - therapeutic use (4) 4
benzamides (4) 4
brca1 (4) 4
child, preschool (4) 4
coronary artery disease (4) 4
cytogenetics (4) 4
deoxyribonucleic acid--dna (4) 4
dermatology (4) 4
diagnosis (4) 4
disease (4) 4
endocrine system diseases (4) 4
gastrointestinal stromal tumors - drug therapy (4) 4
genetic polymorphisms (4) 4
genetic research (4) 4
gist (4) 4
hematology (4) 4
medicine (4) 4
mutation, missense (4) 4
neoplasm staging (4) 4
pediatric mastocytosis (4) 4
phenotype (4) 4
piperazines - therapeutic use (4) 4
proto-oncogene proteins c-kit - metabolism (4) 4
pyrimidines - therapeutic use (4) 4
spectrum (4) 4
systemic mastocytosis (4) 4
therapy (4) 4
alzheimer's disease (3) 3
anaphylaxis (3) 3
article (3) 3
bche (3) 3
biomarkers, tumor - genetics (3) 3
breast-cancer (3) 3
butyrylcholinesterase (3) 3
carcinoma, non-small-cell lung - genetics (3) 3
cardiac & cardiovascular systems (3) 3
cardiovascular disease (3) 3
cdls (3) 3
cholesterol (3) 3
classification (3) 3
clinical neurology (3) 3
cornelia de lange syndrome (3) 3
coronary artery disease - genetics (3) 3
coronary heart disease (3) 3
criteria (3) 3
cutaneous mastocytosis (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of Cancer Research and Clinical Oncology, ISSN 0171-5216, 1/2015, Volume 141, Issue 1, pp. 61 - 68
Testing for the epidermal growth factor receptor (EGFR) gene mutations requires considerable multidisciplinary experience of clinicians (for appropriate... 
Medicine & Public Health | Hematology | Non-small cell lung cancer | Oncology | Cancer Research | Internal Medicine | TTF1 | EGFR gene | Mutation testing | Tyrosine kinase inhibitors | METAANALYSIS | ADENOCARCINOMA | METASTASES | SURGICAL PATHOLOGY SPECIMENS | TRIAL | ONCOLOGY | FACTOR RECEPTOR MUTATIONS | KRAS | INHIBITORS | ASSOCIATION | Receptor, Epidermal Growth Factor - genetics | Prognosis | Follow-Up Studies | Carcinoma, Squamous Cell - genetics | Humans | Middle Aged | Carcinoma, Squamous Cell - surgery | Lung Neoplasms - pathology | Male | Carcinoma, Large Cell - secondary | Carcinoma, Non-Small-Cell Lung - secondary | DNA Mutational Analysis | Polymerase Chain Reaction | Female | Adenocarcinoma - genetics | Carcinoma, Large Cell - genetics | Retrospective Studies | Lung Neoplasms - genetics | Carcinoma, Adenosquamous - surgery | Carcinoma, Non-Small-Cell Lung - surgery | Carcinoma, Non-Small-Cell Lung - genetics | Carcinoma, Adenosquamous - genetics | DNA-Binding Proteins - genetics | Mutation - genetics | Adenocarcinoma - secondary | Carcinoma, Large Cell - surgery | Carcinoma, Adenosquamous - secondary | Carcinoma, Squamous Cell - secondary | Lung Neoplasms - surgery | Aged | Transcription Factors | Neoplasm Staging | Adenocarcinoma - surgery | Care and treatment | Gene mutations | Oncology, Experimental | Genes | Lung cancer, Small cell | Genetic aspects | Research | Lung cancer, Non-small cell | Cancer | Index Medicus | Original – Cancer Research
Journal Article
Oncology Letters, ISSN 1792-1074, 02/2018, Volume 15, Issue 2, pp. 1912 - 1916
Gemcitabine (GCB) is a pyrimidine antimetabolite widely used in various solid tumors as a single agent or as a component of multidrug regimens. In the majority... 
Chemotherapy toxicity | Gemcitabine | Cytidine deaminase | Polymorphism | chemotherapy toxicity | OXIDATIVE DAMAGE | PANCREATIC-CANCER | polymorphism | NUCLEOSIDIC ANALOGS | GENE POLYMORPHISMS | CHEMOTHERAPY | FUNCTIONAL GENOMICS | CELL LUNG-CANCER | CISPLATIN | PHARMACOKINETICS | ONCOLOGY | DRUG TOXICITY | gemcitabine | cytidine deaminase
Journal Article
Scientific Reports, ISSN 2045-2322, 12/2019, Volume 9, Issue 1, pp. 1 - 7
While the life expectancy of the population has increased, Alzheimer’s disease (AD) has emerged as one of the greatest health problems of old age. AD is... 
Apolipoprotein E4 | Peptides | Cognitive ability | Homeostasis | Amino acids | Mass spectroscopy | Single-nucleotide polymorphism | Coexistence | Acetylcholinesterase | Apolipoproteins | Cholesterol | Life span | Apolipoprotein E | Coding | Alleles | Health risk assessment | Alzheimer's disease | Plaques
Journal Article
Oncotarget, ISSN 1949-2553, 2017, Volume 8, Issue 60, pp. 101325 - 101332
Approximately 25% of patients with ovarian cancer harbor a pathogenic BRCA1/2 mutation that has been associated with favorable responses for targeted therapy... 
BRCA1/2 | CtDNA | Next-generation sequencing | PARP1 inhibitor | Ovarian cancer | ovarian cancer | next-generation sequencing | POLYMERASE | POLAND | ctDNA | SOMATIC MUTATIONS | CELL BIOLOGY | BREAST-CANCER | PLASMA | GENE | FREQUENCY | GERMLINE MUTATIONS | INHIBITORS
Journal Article
by Jasiecki and Wasąg
Biomolecules, ISSN 2218-273X, 10/2019, Volume 9, Issue 10, p. 592
: Late-onset Alzheimer’s disease (AD) is clinically characterized by a progressive decline of memory and other cognitive functions leading to the loss of the... 
BChE | rivastigmine | butyrylcholinesterase | BuChE | Alzheimer's disease | pseudocholinesterase | K-variant
Journal Article
Journal Article
Chemico-Biological Interactions, ISSN 0009-2797, 07/2019, Volume 307, pp. 154 - 157
Butyrylcholinesterase (BChE) is a serine hydrolase widely distributed throughout the body. It provides protection against administrated or inhaled poisons by... 
BChE | Gene polymorphisms | Pseudocholinesterase | Butyrylcholinesterase | K-variant | CHOLINESTERASE | BCHE GENE | ALZHEIMERS-DISEASE | BIOCHEMISTRY & MOLECULAR BIOLOGY | RISK | GENETIC-VARIANTS | IDENTIFICATION | APOLIPOPROTEIN E4 | NO ASSOCIATION | POLYMORPHISMS | MUTATION | PHARMACOLOGY & PHARMACY | TOXICOLOGY | Enzymes | Anopheles | Genes | Genetic polymorphisms | Index Medicus
Journal Article
Applied Immunohistochemistry and Molecular Morphology, ISSN 1541-2016, 2018, Volume 26, Issue 1, pp. 40 - 45
Journal Article
Journal of Applied Genetics, ISSN 1234-1983, 5/2015, Volume 56, Issue 2, pp. 193 - 198
Journal Article
Haematologica, ISSN 0390-6078, 06/2011, Volume 96, Issue 6, pp. 922 - 926
We report a patient with T-lymphoblastic leukemia/lymphoma and a t(7;8)(q22;p11). CUX1 was identified as the fusion partner of FGFR1 by fluorescence in situ... 
Myeloid and lymphoid neoplasms with FGFR1 abnormalities (ICD-O 9967/3) | T-lymphoblastic leukemia/lymphoma | TKI258 | 8p11 myeloproliferative syndrome (EMS) | Tyrosine kinase inhibitor | FGFR1 | MUTATION ANALYSIS | MULTIPLE-MYELOMA | TYROSINE KINASE | 8P11 MYELOPROLIFERATIVE SYNDROME | CELL-LINES | myeloid and lymphoid neoplasms with FGFR1 abnormalities (ICD-O 9967/3) | CHIR-258 | MODELS | GENES | DISORDER | tyrosine kinase inhibitor | LEUKEMIA | HEMATOLOGY | Chromosomes, Human, Pair 8 - genetics | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Oncogene Proteins, Fusion - metabolism | Homeodomain Proteins - metabolism | Humans | Receptor, Fibroblast Growth Factor, Type 1 - metabolism | Repressor Proteins - genetics | Nuclear Proteins - metabolism | Receptor, Fibroblast Growth Factor, Type 1 - genetics | Homeodomain Proteins - genetics | Cell Transformation, Neoplastic | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - genetics | Protein Kinase Inhibitors - therapeutic use | Base Sequence | Cell Line, Tumor | Cytogenetics | Adult | Female | Cell Proliferation - drug effects | Protein Kinase Inhibitors - pharmacology | Chromosomes, Human, Pair 7 - genetics | Nuclear Proteins - genetics | Repressor Proteins - metabolism | Translocation, Genetic - genetics | T-lymphoblastic leukemia | Brief Reports | myeloid and lymphoid neoplasms with FGFR1 abnormalities (ICD-O 9967 | lymphoma
Journal Article
International Archives of Allergy and Immunology, ISSN 1018-2438, 12/2014, Volume 165, Issue 2, pp. 104 - 110
Journal Article